Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Lavior
AddedFeb 16, 2024
UpdatedJun 18, 2026
Lavior

Lavior

Seed

LAVIOR: Non-Rx skincare solutions for challenging diabetic skin conditions.

HQ
Miami, FL, US
Founded
2013
Overview
Compare
Fundraising
Employees
Website

Founded with a mission to provide non-prescription skincare solutions, Lavior focuses on developing products that address challenging diabetic skin conditions. The company offers a uniquely formulated line of treatments aimed at healing wounds, diabetic ulcers, and deep tissue injuries through a single, comprehensive approach. Lavior's products are designed to replace and complement other treatments, simplifying wound management for patients and healthcare providers alike.

Lavior's skincare solutions are clinically proven and physician-approved, demonstrating efficacy in treating some of the toughest wounds. The company's notable achievements include repeated successful clinical tests and widespread adoption among healthcare professionals. By offering an effective and accessible treatment option, Lavior has made a significant impact on the management of diabetic skin conditions, improving the quality of life for many patients.

Lavior - Similar Companies

Melliderm logo

Melliderm

CureSkin logo

CureSkin

cureskin.com

Stratia logo

Stratia

stratiaskin.com

Skin Laundry logo

Skin Laundry

skinlaundry.com

Curology logo

Curology

curology.com

FutureDerm logo

FutureDerm

Skin Pharm logo

Skin Pharm

skinpharm.com

Dermal Life logo

Dermal Life

DermApproved logo

DermApproved

dermapproved.com

Topicals logo

Topicals

mytopicals.com

Soteri Skin logo

Soteri Skin

soteriskin.com

Hydrinity logo

Hydrinity

hydrinity.com

aavrani logo

aavrani

aavrani.com

Eighth Day Skin logo

Eighth Day Skin

eighthdayskin.com

Dermaliq Therapeutics logo

Dermaliq Therapeutics

dermaliq.com

Lavior - Quick Facts

Who are Lavior's competitors?

Companies similar to Lavior include Melliderm, CureSkin, Stratia and Skin Laundry.

When was Lavior founded?

Lavior was founded in 2013.

Where is Lavior's headquarters located?

Lavior's headquarters is located in Miami, FL, US.

When was Lavior's last funding round?

Lavior's most recent funding round was for $580k (USD) in September 2021.

How much has Lavior raised to-date?

As of Sep 24, 2021, Lavior has raised a total of $580k (USD).

How many employees does Lavior have?

Lavior has 13 employees as of Feb 5, 2024.

Lavior - Classification

Industry
  • Retail
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Transactional
Customer
  • Consumers
Main Product
  • Skincare
  • Wound Care
Tags
  • eCommerce
  • Healthtech
NAICS
  • 320000Manufacturing
  • 325600Soap, Cleaning Compound, and Toilet Preparation Manufacturing
  • 325620Toilet Preparation Manufacturing
  • 325000Chemical Manufacturing
SIC
  • 2844Perfumes, Cosmetics, And Other Toilet Preparations
  • 2800Chemicals And Allied Products
Show 6 more industry codes
NAICS
  • 330000Manufacturing
  • 620000Health Care and Social Assistance
SIC
  • 3900Miscellaneous Manufacturing Industries
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified